Formation Bio, an AI-native pharma company, today announced dosing of the first participant in a Phase 1, first-in-human (FIH) clinical trial of BLKR201. The study, BLKR201-101-HV, is a single ...

I began teaching Australian literature not long after the death of Alec Derwent (A.D.) Hope (1907-2000). Despite Hope’s ...

Georgia Tech professor Matthew Hild wrote "A Little More Love: The Life and Legacy of Olivia Newton-John,” which looks at the ...

When I was in college I learned about the great man theory of history. I didn’t quite buy it. And now, thanks to President ...

Dhruvajit Hatibaruah, an Economics graduate from Assam, chose self-reliance over a government job. Starting with 20 silkworms ...

The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.

For Chicago residents who live in food deserts, the future of access to fresh, affordable meat has become increasingly ...

G2G Bio has released preclinical data at a global conference, demonstrating the potential for developing a long-acting ...

PD-L1 × TIGIT × LAG3 format enables simultaneous interrogation of three complementary checkpoint pathways within a single in ...

Jefferies Global Healthcare Conference 2026 June 3, 2026 8:45 AM EDTCompany ParticipantsRoop Lakkaraju - Executive VP ...

Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in ...

Treos Bio, a clinical-stage company developing off-the-shelf and personalized active cancer immunotherapies, today announced three abstracts on its proprietary Promiscuous EPItopes (PEPI) Technology ...